CORT
Price
$69.36
Change
-$0.01 (-0.01%)
Updated
Sep 5 closing price
Capitalization
7.31B
53 days until earnings call
TENX
Price
$6.00
Change
-$0.01 (-0.17%)
Updated
Sep 5 closing price
Capitalization
27.35M
Interact to see
Advertisement

CORT vs TENX

Header iconCORT vs TENX Comparison
Open Charts CORT vs TENXBanner chart's image
Corcept Therapeutics
Price$69.36
Change-$0.01 (-0.01%)
Volume$967.03K
Capitalization7.31B
Tenax Therapeutics
Price$6.00
Change-$0.01 (-0.17%)
Volume$10.06K
Capitalization27.35M
CORT vs TENX Comparison Chart in %
Loading...
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORT vs. TENX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORT is a Buy and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CORT: $69.36 vs. TENX: $5.99)
Brand notoriety: CORT and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CORT: 121% vs. TENX: 55%
Market capitalization -- CORT: $7.31B vs. TENX: $27.35M
CORT [@Biotechnology] is valued at $7.31B. TENX’s [@Biotechnology] market capitalization is $27.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORT’s FA Score shows that 1 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • CORT’s FA Score: 1 green, 4 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than TENX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORT’s TA Score shows that 3 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • CORT’s TA Score: 3 bullish, 5 bearish.
  • TENX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TENX is a better buy in the short-term than CORT.

Price Growth

CORT (@Biotechnology) experienced а -0.52% price change this week, while TENX (@Biotechnology) price change was +0.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CORT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORT($7.31B) has a higher market cap than TENX($27.4M). CORT has higher P/E ratio than TENX: CORT (61.93) vs TENX (2.04). CORT YTD gains are higher at: 37.646 vs. TENX (-3.150). CORT has higher annual earnings (EBITDA): 104M vs. TENX (-31.48M). CORT has more cash in the bank: 342M vs. TENX (105M). TENX has less debt than CORT: TENX (279K) vs CORT (6.61M). CORT has higher revenues than TENX: CORT (716M) vs TENX (0).
CORTTENXCORT / TENX
Capitalization7.31B27.4M26,675%
EBITDA104M-31.48M-330%
Gain YTD37.646-3.150-1,195%
P/E Ratio61.932.043,035%
Revenue716M0-
Total Cash342M105M326%
Total Debt6.61M279K2,367%
FUNDAMENTALS RATINGS
CORT vs TENX: Fundamental Ratings
CORT
TENX
OUTLOOK RATING
1..100
8668
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
4297
PRICE GROWTH RATING
1..100
4452
P/E GROWTH RATING
1..100
992
SEASONALITY SCORE
1..100
n/a12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (13) in the Medical Specialties industry is significantly better than the same rating for CORT (81) in the Pharmaceuticals Other industry. This means that TENX’s stock grew significantly faster than CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for TENX (100) in the Medical Specialties industry. This means that CORT’s stock grew somewhat faster than TENX’s over the last 12 months.

CORT's SMR Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for TENX (97) in the Medical Specialties industry. This means that CORT’s stock grew somewhat faster than TENX’s over the last 12 months.

CORT's Price Growth Rating (44) in the Pharmaceuticals Other industry is in the same range as TENX (52) in the Medical Specialties industry. This means that CORT’s stock grew similarly to TENX’s over the last 12 months.

CORT's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for TENX (92) in the Medical Specialties industry. This means that CORT’s stock grew significantly faster than TENX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORTTENX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIDCX27.140.07
+0.26%
American Funds Income Fund of Amer R3
FRVFX48.50N/A
N/A
Franklin Small Cap Value C
PINTX11.48N/A
N/A
Principal Overseas R3
CAVAX17.37N/A
N/A
SEI Catholic Values Equity F (SCVT)
NDGAX24.71N/A
N/A
Neuberger Berman Dividend Growth A

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-0.01%
VTVT - CORT
48%
Loosely correlated
-1.24%
TENX - CORT
41%
Loosely correlated
-0.08%
AGIO - CORT
41%
Loosely correlated
-0.33%
DNLI - CORT
40%
Loosely correlated
+4.33%
ARCT - CORT
37%
Loosely correlated
+6.50%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
-0.08%
AVXL - TENX
47%
Loosely correlated
+0.43%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
-0.01%
ADVM - TENX
36%
Loosely correlated
+11.04%
COYA - TENX
27%
Poorly correlated
-1.72%
More